<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Of patients who are prescribed <z:chebi fb="0" ids="6801">metformin</z:chebi>, 10-30% have evidence of reduced <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> absorption </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="13" ids="33611">B12</z:chebi>-intrinsic factor complex uptake by ileal cell surface receptors is known to be a process dependent on calcium availability <z:chebi fb="0" ids="6801">Metformin</z:chebi> affects calcium-dependent membrane action </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of this study was to determine the magnitude and mechanism of the reduction in serum <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> after <z:chebi fb="0" ids="6801">metformin</z:chebi> administration </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: A comparative study design was employed using 2 groups (<z:chebi fb="0" ids="6801">metformin</z:chebi> and control) </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 21 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> received <z:chebi fb="0" ids="26831">sulfonylurea</z:chebi> therapy; 14 of these 21 patients were switched to <z:chebi fb="0" ids="6801">metformin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Monthly serum total <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> measurements and holotranscobalamin (holoTCII) (<z:chebi fb="13" ids="33611">B12</z:chebi>-TCII) were performed </plain></SENT>
<SENT sid="6" pm="."><plain>After 3 months of <z:chebi fb="0" ids="6801">metformin</z:chebi> therapy, oral calcium supplementation was administered </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Serial serum <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> determinations revealed a similar decline in <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> and holoTCII </plain></SENT>
<SENT sid="8" pm="."><plain>Oral calcium supplementation reversed the <z:chebi fb="0" ids="6801">metformin</z:chebi>-induced serum holoTCII <z:hpo ids='HP_0000716'>depression</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Patients receiving <z:chebi fb="0" ids="6801">metformin</z:chebi> have diminished <z:chebi fb="13" ids="33611">B12</z:chebi> absorption and low serum total <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> and TCII-<z:chebi fb="13" ids="33611">B12</z:chebi> levels because of a calcium-dependent ileal membrane antagonism, an effect reversed with supplemental calcium </plain></SENT>
</text></document>